Clinical trials
Phase 2 Overweight trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| AstraZeneca | 3 |
| Golo | 2 |
| Novo Nordisk A/S | 2 |
| Amgen | 1 |
| Boehringer Ingelheim | 1 |
| Carmot Therapeutics, Inc. | 1 |
| May Faraj, PDt, PhD | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 19 |
| Overweight | 19 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 2 |
| Prediabetic State | 2 |
| Body Weight | 1 |
| Glucose Intolerance | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Nutrition Disorders | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.